Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01267045 · ClinicalTrials.gov registry record · NA

Mindfulness-Based Stress Reduction for Gulf War Syndrome

A NA study of Persian Gulf Syndrome, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
55
Enrollment target
1
Study location

NCT01267045: Completed NA study of Persian Gulf Syndrome, sponsored by US Department of Veterans Affairs.

NCT01267045 is a NA study of Persian Gulf Syndrome that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 55 participants, below the 112-participant average among 4 other Persian Gulf Syndrome trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01267045, a NA study of Persian Gulf Syndrome, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target
1
Study location

Study Summary

This pilot study is a two arm randomized, controlled clinical trial that evaluated whether a standardized Mindfulness-Based Stress Reduction (MBSR) intervention reduces symptoms associated with Gulf War Syndrome (GWS) more effectively than treatment as usual. Fifty-five veterans meeting diagnostic criteria for Gulf War Syndrome were randomized to treatment as usual (TAU) or TAU plus an 8-week course of course of MBSR. Study measures were collected at baseline, immediate post-MBSR, and 6 months post intervention. Measures were obtained at equivalent time points for veterans randomized to TAU only. Following completion of all study activities, veterans randomized to TAU only had the opportunity to enroll in MBSR.

Primary Outcome

The Short-Form McGill Pain Questionnaire is a self-report 22-item measure that assesses various types of pain on a scale of 0 (none) to 10 (worst possible) experienced during the past week. Score ranges from a minimum of 0 to a maximum of 220; the higher the score, the worse the outcome.

Conditions Studied

Interventions

  • BEHAVIORAL Mindfulness-based stress reduction

Study Locations (1)

Washington

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA - Seattle

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2010-10
Est. Completion 2014-04
Phase NA
US Department of Veterans Affairs

632 total trials

What the finished NCT01267045 record still lists

NCT01267045 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 112-participant average among 4 other Persian Gulf Syndrome trials with a reported enrollment target (51% lower).

The record links to 1 condition, with Persian Gulf Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness-based stress reduction is the first listed.

NCT01267045 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT01267045 about?

NCT01267045 is a clinical study titled "Mindfulness-Based Stress Reduction for Gulf War Syndrome". This pilot study is a two arm randomized, controlled clinical trial that evaluated whether a standardized Mindfulness-Based Stress Reduction (MBSR) intervention reduces symptoms associated with Gulf War Syndrome (GWS) more effectively than treatment as usual. Fifty-five veterans meeting diagnostic c...

What is the current status of trial NCT01267045?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2010-10. Estimated completion is 2014-04.

What conditions does trial NCT01267045 study?

This clinical trial studies the following conditions: Persian Gulf Syndrome.

What interventions are being tested in trial NCT01267045?

The interventions under investigation include: Mindfulness-based stress reduction (BEHAVIORAL).

Who is sponsoring clinical trial NCT01267045?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01267045 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Persian Gulf Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01638676 · 55 participants · Phase 1

    A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

  • NCT01906385 · 55 participants · Phase 1

    Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

  • NCT03007030 · 55 participants · Phase 2

    Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery

  • NCT03152058 · 55 participants · Phase 2

    IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01267045, the US trial registry maintained by the National Library of Medicine. NCT01267045 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.